Does Your PV Function Effectively Support Your Company’s Objectives?

Organic growth, mergers, acquisitions and regulatory changes have resulted in an inefficient PV System with the links between people, process and technology not as effective as they could be include:

  • Inability to scale up to handle annual growth in ICSRs
  • Poor cross-functional collaboration
  • Misaligned roles, responsibilities, and governance structures
  • Lack of consistency in processes across countries and regions
  • Increased regulatory findings
  • Limited visibility of metrics that measure compliance, effectiveness, and efficiency
  • Lack of system integration

Navitas Life Sciences Provides an Integrated Approach Leading to Impactful Results

  • Proven methodology to systematically assess people, process and technology
  • Cross-functional collaborationwith business SMEs to design streamlined value-adding processes
  • End-to-End scope includes
  • Harmonizing and simplifying regional process differences
  • Integrating new data sources
  • Planning for case volume scale-up
  • Aligning with new regulatory requirement
end-to-end pv optimization

Deliverables

  • Process gap analysis and improvement opportunities
  • Integrated and optimized processes
  • Updated and aligned governance structures
  • Updated roles and responsibilities
  • Resource plan to support new processes
  • Technology assessment and recommendations
  • Implementation roadmap
  • Change management plan

Benefits

Optimized and Harmonized PV Systems Including:

  • Scalable processes to manage increasing case volumes
  • Harmonized processes to support compliance
  • Proactive risk management
  • Streamlining of worldwide PV Operations
  • Improved oversight through meaningful, accurate, and timely metrics

Latest News & Articles

31
Dec2019

Encouraging patient-centric innovation in pharma

Dr Ayaaz Hussain Khan, Global Head Generics, Navitas Life Sciences (a TAKE Solutions...

17
Dec2019

Barriers Preventing Clinical Trial Software Development

Back in August of 2011 in the Wall Street Journal, Marc Andressen, the...